TRV GP’s KALA BIO KALA Stock Holding History

TRV GP’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-662	Closed	-$22.7M	–	5
2018 Q2	$22.7M	Hold	662	–	–	14.31%	2
2018 Q1	$26.2M	Hold	662	–	–	18.56%	3
2017 Q4	$30.6M	Buy	+662	New	+$31M	13.82%	3

Other funds holding KALA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TRV GP's KALA Position: Q3 2018 in Review

TRV GP sold out of KALA BIO (KALA) in Q3 2018, closing a stake of 662 shares — an estimated $22.7M sold.

TRV GP first reported a position in KALA in Q4 2017 and held it in 3 quarters. The position peaked at $30.6M in Q4 2017. 59 funds tracked by Wall St. Rank hold KALA as of Q3 2018.

TRV GP reported no remaining KALA BIO position as of Q3 2018 after selling out during the quarter.
TRV GP sold 662 KALA BIO shares in Q3 2018, an estimated $22.7M.
TRV GP first reported a position in KALA BIO in Q4 2017 and held it in 3 quarters.
TRV GP's KALA BIO position peaked at $30.6M in Q4 2017.
59 funds tracked by Wall St. Rank held KALA BIO as of Q3 2018.

Based on TRV GP's 13F filing for Q3 2018, filed 29 Oct 2018.